Matthew Campobasso Sells 1,081 Shares of Enfusion, Inc. (NYSE:ENFN) Stock

Enfusion, Inc. (NYSE:ENFN) General Counsel Matthew Campobasso sold 1,081 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $11.48, for a total transaction of $12,409.88. Following the completion of the sale, the general counsel now owns 72,641 shares of the company’s stock, valued at approximately $833,918.68. This trade represents a 1.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Matthew Campobasso also recently made the following trade(s):

• On Tuesday, January 7th, Matthew Campobasso sold 976 shares of Enfusion stock. The shares were sold at an average price of $10.13, for a total transaction of $9,886.88.

Enfusion Trading Up 0.4 %

ENFN opened at $11.45 on Thursday. The firm’s 50-day moving average price is $10.95 and its 200 day moving average price is $9.85. The firm has a market capitalization of $1.47 billion, a PE ratio of 286.20, a PEG ratio of 1.85 and a beta of 0.96. Enfusion, Inc. has a twelve month low of $7.83 and a twelve month high of $11.80.

Enfusion (NYSE:ENFN) last released its quarterly earnings results on Monday, March 3rd. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The company had revenue of $52.94 million during the quarter, compared to analysts’ expectations of $53.98 million. Enfusion had a net margin of 1.70% and a return on equity of 6.67%. As a group, analysts predict that Enfusion, Inc. will post 0.06 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Enfusion

Several large investors have recently added to or reduced their stakes in ENFN. KLP Kapitalforvaltning AS purchased a new stake in Enfusion during the 4th quarter worth approximately $75,000. Harbor Capital Advisors Inc. increased its stake in Enfusion by 12.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock worth $113,000 after buying an additional 1,315 shares during the period. Belvedere Trading LLC purchased a new stake in Enfusion during the 3rd quarter worth approximately $114,000. Millennium Management LLC purchased a new stake in Enfusion during the 4th quarter worth approximately $114,000. Finally, Dark Forest Capital Management LP purchased a new stake in Enfusion during the 4th quarter worth approximately $128,000. 81.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ENFN has been the subject of several recent analyst reports. William Blair restated a “market perform” rating on shares of Enfusion in a research note on Monday, January 13th. Piper Sandler raised their price target on shares of Enfusion from $10.00 to $11.50 and gave the stock a “neutral” rating in a report on Monday, December 23rd. Finally, Stifel Nicolaus raised their price target on shares of Enfusion from $11.00 to $13.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $11.13.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.